# Angiotensin-(1-7) in Treating Patients With Metastatic or Unresectable Solid Tumors

> **NCT00471562** · PHASE1 · COMPLETED · sponsor: **Wake Forest University Health Sciences** · enrollment: 18 (actual)

## Conditions studied

- Unspecified Adult Solid Tumor, Protocol Specific

## Interventions

- **BIOLOGICAL:** therapeutic angiotensin-(1-7)

## Key facts

- **NCT ID:** NCT00471562
- **Lead sponsor:** Wake Forest University Health Sciences
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-03
- **Primary completion:** 2009-10
- **Final completion:** 2009-10
- **Target enrollment:** 18 (ACTUAL)
- **Last updated:** 2017-08-01

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00471562

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00471562, "Angiotensin-(1-7) in Treating Patients With Metastatic or Unresectable Solid Tumors". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT00471562. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*